Imidazolium Interpenetrated and Interlocked Assemblies
FULL PAPER
an MBraun MPSP-800 column. Water was de-ionized and microfiltered
using a Milli-Q Millipore machine. All tetrabutylammonium salts and
Grubbsꢅ second-generation catalyst were stored in a vacuum desiccator
prior to use.
Conclusion
An investigation into the imidazolium–anion interaction was
undertaken through the anion-templated assembly and syn-
thesis of interpenetrated and interlocked structures. Solu-
tion-phase studies, solid-state structures, computational MD
simulations, and DFT calculations suggest that the strength
of anion binding, commonly thought to occur through
charge-assisted hydrogen bonding, is influenced more by
electrostatics than conventional hydrogen bonding.
In particular, the solid-state structure orientations of imi-
dazolium threading components within the pseudorotaxane
assemblies appear to show weak dependence on any direc-
tional interactions with the templating chloride anion and
contrasting co-conformations with respect to solution-phase
NMR studies. This was investigated by using MD simula-
tions, which illustrate 4,5-dimethylimidazolium thread rota-
tion within the chloride interpenetrated assembly from the
solid-state structure to the co-conformation observed in so-
lution. In contrast, the equivalent event was not observed
for the 2-methylimidazolium derivative.
Further evidence was obtained from the preparation of
the first mono-imidazolium interlocked structures and their
anion binding properties. The topologically well-defined,
three-dimensional interlocked binding cavities within the
host rotaxanes displayed significant selectivity for the spher-
ical halide anions over the larger, more basic oxoanions,
however with limited preference between the halides. The
only difference in the anion-binding properties between the
rotaxanes, which incorporate imidazolium groups of con-
trasting hydrogen-bond donor geometries, was stronger
binding for the 4,5-dimethylimidazolium system. This sug-
gests that the imidazolium–halide anion binding interaction
within the interlocked cavity is electrostatically dominated
and less dependent on the exact hydrogen-bonding arrange-
ment.
It is concluded that viewing the interaction between the
imidazolium cation and counter anion as charge-assisted hy-
drogen bonding is inadequate when considering the con-
struction, co-conformations and properties of interpenetrat-
ed and interlocked assemblies in the field of anion-coordina-
tion chemistry. We suggest that such interactions might be
better described as charge-driven hydrogen bonding. Our
findings for the acyclic, pseudorotaxane and rotaxane sys-
tems described herein indicate that, in anion recognition,
electrostatic interactions dominate with respect to imidazoli-
um–anion binding, with the hydrogen-bonding contributions
having weak orientational dependence, and are therefore of
fundamental significance for the future design of imidazol-
NMR spectra were recorded on Varian Mercury 300, Varian Unity Plus
500 and Bruker AVII 500 (with 13C Cryoprobe) spectrometers. Mass
spectrometry was carried out on a Bruker micrOTOF spectrometer. Mi-
crowave reactions were carried out using a Biotage Initiator 2.0 micro-
wave. Melting points were recorded on a Gallenkamp capillary melting
point apparatus and are uncorrected.
Literature procedures were used in the preparation of 1·Cl, 2·Cl,[19] 3,[18]
and 6.[14] The syntheses of 1·PF6, 2·PF6, 4·Cl, and 5·Cl are given in the
Supporting Information.
Rotaxane 7·Cl: Axle 4·Cl (200 mg, 0.164 mmol) and macrocycle precursor
6 (106 mg, 0.164 mmol) were dissolved in dry CH2Cl2 (50 mL) and stirred
for 1 h. Grubbsꢅ second-generation catalyst (10% by weight, 10.6 mg)
was then added and the reaction mixture was left to stir at room temper-
ature for two days under N2. The solvent was removed in vacuo and the
crude product was purified by preparative silica thin-layer chromatogra-
phy (94:6 CH2Cl2/CH3OH followed by 4:6 CH2Cl2/CH3CN) to yield the
product as an off white solid (90 mg, 0.049 mmol, 30%). M.p. 167–1698C
(decomp); 1H NMR (500 MHz, CDCl3): d=10.03 (s, 1H; Hb), 9.79 (s,
1H; H1), 9.36 (br s, 2H; Hc), 9.09 (s, 2H; Ha), 7.23–7.26 (m, 12H; H9),
7.08–7.13 (m, 16H; H7 & H8), 6.64–6.66 (m, 4H; H6), 6.36–6.42 (m, 8H;
Hf & Hg), 5.82 (br s, 2H; Hk), 4.15–4.17 (m, 4H; He), 3.97 (br s, 4H; Hj),
3.92–3.94 (m, 4H; Hd), 3.81–3.82 (m, 4H; Hh), 3.69–3.70 (m, 4H; Hi),
3.62–3.64 (m, 4H; H5), 3.57–3.60 (m, 4H; H3), 1.94–1.97 (m, 4H; H4),
1.88 (s, 6H; H2), 1.27 ppm (s, 54H; H10); 13C NMR (75.5 MHz, CDCl3): d
= 164.2, 155.7, 152.7, 152.3, 149.0, 148.3, 144.0, 140.5, 135.6, 132.4, 130.6,
128.8, 126.4, 126.0, 124.1, 114.5, 113.8, 112.7, 70.9, 69.2, 67.7, 66.4, 63.7,
63.0, 43.8, 40.4, 34.3, 31.4, 28.7, 8.0 ppm; HRMS (ESI): m/z: [MꢀCl]+
1808.0551 C117H140N5O12 (calcd 1808.0526).
Rotaxane 7·PF6: Rotaxane 7·Cl (50 mg, 0.027 mmol) was dissolved in
CH2Cl2 (10 mL) and washed with 0.1m NH4PF6 (aq) (1010 mL) and
water (410 mL). The organic fraction was dried over MgSO4 and in
vacuo to yield the product as an off white solid (49 mg, 0.025 mmol,
93%). M.p. 158–1598C (decomp); 1H NMR (300 MHz, CDCl3): d =9.02
(s, 2H; Ha), 8.40 (br s, 1H; Hb), 7.97 (s, 1H; H1), 7.23–7.26 (m, 12H; H9),
3
7.08–7.15 (m, 16H; H7 & H8), 6.68–6.71 (m, 4H; H6), 6.57 (d, J =8.8 Hz,
4H; Hf), 6.33 (d, 3J =8.8 Hz, 4H; Hg), 5.83 (br s, 2H; Hk), 4.08–4.11 (m,
4H; He), 3.89–3.95 (br s, 8H; Hd & Hj), 3.76–3.79 (m, 8H; Hh & H5),
3.61–3.68 (m, 8H; Hi & H3), 1.91–1.98 (m, 4H; H4), 1.89 (s, 6H; H2),
1.31 ppm (s, 54H; H10); 19F NMR (282.5 MHz, CDCl3): d=ꢀ70.1 ppm (d,
1J= 760 Hz; PF6); 13C NMR (75.5 MHz, CDCl3): d=164.4, 155.7, 153.0,
152.2, 149.0, 148.3, 144.0, 140.5, 136.4, 132.3, 130.6, 129.6, 126.9, 126.6,
124.1 114.9, 113.8, 112.8, 70.8, 69.3, 67.5, 66.6, 63.5, 63.0, 44.0, 40.0, 34.3,
31.4, 28.7, 7.8 ppm; HRMS (ESI): m/z: [MꢀPF6]+ 1808.0535
C
117H140N5O12 (calcd 1808.0526).
Rotaxane 8·Cl: Axle 5·Cl (200 mg, 0.166 mmol) and macrocycle precursor
6 (108 mg, 0.166 mmol) were dissolved in dry CH2Cl2 (50 mL) and stirred
for 1 h. Grubbsꢅ second-generation catalyst (10% by weight, 10.8 mg)
was then added and the reaction mixture was left to stir at room temper-
ature for two days under N2. The solvent was removed in vacuo and the
crude product was purified by preparative silica thin-layer chromatogra-
phy (95:5 CH2Cl2/CH3OH followed by ethyl acetate) to yield the product
as an off white solid (58 mg, 0.031 mmol, 19%). M.p. 162–1648C
(decomp); 1H NMR (300 MHz, CDCl3): d =9.96 (s, 1H; Hb), 9.40 (br s,
2H; Hc), 9.08 (s, 2H; Ha), 7.47 (s, 2H; H1’), 7.24–7.27 (m, 12H; H9’),
7.09–7.16 (m, 16H; H7ꢅ & H8’), 6.67–6.70 (m, 4H; H6’), 6.55 (d, 3J=
8.8 Hz, 4H; Hf), 6.33 (d, 3J=8.8 Hz, 4H; Hg), 5.82 (br s, 2H; Hk), 4.17–
4.20 (m, 4H; He), 3.97–4.02 (m, 4H; Hd), 3.92 (br s, 4H; Hj), 3.78–3.79
(m, 4H; Hh), 3.65–3.73 (m, 12H; Hi & H3ꢅ & H5’), 2.07 (s, 3H, H2’), 1.86–
1.94 (m, 4H; H4’), 1.31 ppm (s, 54H; H10’); 13C NMR (75.5 MHz, CDCl3):
d=164.3, 155.7, 153.2, 152.0, 148.9, 148.4, 143.9, 142.5, 140.6, 135.7, 132.4,
130.6, 129.2, 126.3, 124.1, 121.2, 115.1, 113.7, 112.8, 70.8, 69.4, 67.4, 67.0,
63.5, 63.0, 45.1, 39.9, 34.3, 31.4, 28.8, 8.7 ppm; HRMS (ESI): m/z:
[MꢀCl]+ 1794.0417 C116H138N5O12 (calcd 1794.0388).
ACHTUNGTRENNUNGium-based anion–host systems.
Experimental Section
General considerations: Commercially available solvents and chemicals
were used without further purification unless otherwise stated. Dry sol-
vents were obtained by purging with nitrogen and then passing through
Chem. Eur. J. 2011, 17, 12955 – 12966
ꢃ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
12965